{"GPL24532": [{"GSM3359411": [{"title": "GPA N1004"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Active;\tbatch: 1;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): ActiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: MPO;\tage: 62;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 6;\tflares (number of relapses): 8;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 4;\tbvas: 7;\tvdi: 10;\tsmoking_pkyrs: 5;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 30;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: Y;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359412": [{"title": "GPA N1007"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Inactive;\tbatch: 1;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): InactiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: PR3;\tage: 43;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 5;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 1;\tsmoking_pkyrs: 19;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359413": [{"title": "GPA N1017"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Never;\tbatch: 1;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): NoNasalGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: PR3;\tage: 64;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 0.75;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 0;\tsmoking_pkyrs: 20;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 5;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Azathioprine;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359414": [{"title": "Control N1025"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 1;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Healthy;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 67;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 25;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359415": [{"title": "Control N1030"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 1;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Sarcoidosis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 63;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 2;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 40;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 15;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: Y;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359416": [{"title": "Control N1033"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 1;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Sarcoidosis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 67;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 1;\tflares (number of relapses): 2;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 30;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 15;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 1"}]}, {"GSM3359417": [{"title": "Control N1006"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 1;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): AllergicRhinitis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 52;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359418": [{"title": "Control N1009"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 1;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Healthy;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 61;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359419": [{"title": "GPA N1011"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Inactive;\tbatch: 1;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): InactiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: PR3;\tage: 54;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 3;\tflares (number of relapses): 1;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 0;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359420": [{"title": "Control N1012"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 1;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): AllergicRhinitis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 52;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 15;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Rituximab;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359421": [{"title": "Control N1014"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 1;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Healthy;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 59;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359422": [{"title": "GPA N1015"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Active;\tbatch: 1;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): ActiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Limited;\tanca: PR3;\tage: 19;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 5;\tflares (number of relapses): 6;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 3;\tbvas: 3;\tvdi: 2;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 7;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Rituximab;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359423": [{"title": "GPA N1018"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Inactive;\tbatch: 1;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): InactiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Limited;\tanca: MPO;\tage: 72;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 10;\tflares (number of relapses): 3;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 2;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): Azathioprine;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359424": [{"title": "GPA N1021"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Never;\tbatch: 1;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): NoNasalGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: MPO;\tage: 54;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 4;\tflares (number of relapses): 2;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 3;\tsmoking_pkyrs: 15;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 40;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Cyclophosphamide;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359425": [{"title": "GPA N1026"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Never;\tbatch: 1;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): NoNasalGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: PR3;\tage: 78;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 6;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 2;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359426": [{"title": "Control N1029"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 1;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Sarcoidosis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 51;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 2;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): Methotrexate;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359427": [{"title": "GPA N1001"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Inactive;\tbatch: 2;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): InactiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Limited;\tanca: PR3;\tage: 31;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 3;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 0;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 2.5;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Methotrexate;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359428": [{"title": "Control N1002"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 2;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Healthy;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 27;\trace: White;\tgender: M;\tethnicity: Hispanic;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359429": [{"title": "GPA N1013"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Never;\tbatch: 2;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): NoNasalGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Limited;\tanca: PR3;\tage: 61;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 17;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 0;\tsmoking_pkyrs: 94;\tsmoking_status: Current;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): Methotrexate;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359430": [{"title": "GPA N1016"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Inactive;\tbatch: 2;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): InactiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Limited;\tanca: PR3;\tage: 51;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 7;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 1;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359431": [{"title": "Control N1019"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 2;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Healthy;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 76;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 40;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359432": [{"title": "GPA N1024"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Inactive;\tbatch: 2;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): InactiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: PR3;\tage: 67;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 4;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 2;\tsmoking_pkyrs: 20;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): Methotrexate;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359433": [{"title": "Control N1027"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 2;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Sarcoidosis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 69;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 6;\tflares (number of relapses): 2;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 15;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359434": [{"title": "Control N1028"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 2;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Sarcoidosis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 40;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 1;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 10;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 1"}]}, {"GSM3359435": [{"title": "GPA N1031"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Never;\tbatch: 2;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): NoNasalGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: PR3;\tage: 44;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 2;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 2;\tsmoking_pkyrs: 5;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): Methotrexate;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359436": [{"title": "Control N1032"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 2;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Healthy;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 47;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359437": [{"title": "GPA N1034"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Inactive;\tbatch: 2;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): InactiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: PR3;\tage: 48;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 2;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 0;\tsmoking_pkyrs: 30;\tsmoking_status: Current;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359438": [{"title": "Control N1036"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 2;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): AllergicRhinitis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 39;\trace: Asian;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: Y;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359439": [{"title": "Control N1037"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 2;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Sarcoidosis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 44;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 8;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): Cyclophosphamide;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359440": [{"title": "Control N1038"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 2;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): AllergicRhinitis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 18;\trace: Black;\tgender: F;\tethnicity: Hispanic;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: Y;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359441": [{"title": "GPA N1040"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Active;\tbatch: 2;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): ActiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Limited;\tanca: PR3;\tage: 32;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 3;\tflares (number of relapses): 1;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 2;\tbvas: 2;\tvdi: 0;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): Methotrexate;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359442": [{"title": "GPA N1041"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Active;\tbatch: 2;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): ActiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: MPO;\tage: 56;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 1.5;\tflares (number of relapses): 1;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 2;\tbvas: 3;\tvdi: 3;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 7.5;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Rituximab;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: Y;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359443": [{"title": "Control N1093"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Sarcoidosis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 28;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 1.5;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: 0;\tsmoking_pkyrs: 2;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359444": [{"title": "GPA N1003"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Inactive;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): InactiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Limited;\tanca: MPO;\tage: 63;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 5;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 5;\tsmoking_pkyrs: 100;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: Y;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359445": [{"title": "GPA N1042A"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Active;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): ActiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Limited;\tanca: PR3;\tage: 42;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 0.3;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 3;\tbvas: 4;\tvdi: 0;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 50;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 1"}]}, {"GSM3359446": [{"title": "Control N1043B"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Healthy;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 38;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359447": [{"title": "GPA N1044B"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Active;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): ActiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Limited;\tanca: PR3;\tage: 40;\trace: White;\tgender: M;\tethnicity: Hispanic;\tdisease_duration (yrs): 0.8;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 4;\tbvas: 5;\tvdi: 2;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 15;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Azathioprine;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359448": [{"title": "GPA N1048B"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Active;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): ActiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: PR3;\tage: 63;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 8;\tflares (number of relapses): 1;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 5;\tbvas: 10;\tvdi: 5;\tsmoking_pkyrs: 50;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 30;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Azathioprine;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359449": [{"title": "GPA N1050A"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Active;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): ActiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Limited;\tanca: PR3;\tage: 44;\trace: Arabic;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 0.8;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 1;\tbvas: 1;\tvdi: 0;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 7.5;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Methotrexate;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359450": [{"title": "GPA N1052A"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Never;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): NoNasalGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: PR3;\tage: 69;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 13;\tflares (number of relapses): 1;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 3;\tsmoking_pkyrs: 7;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 5;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Mycophenolate mofetil;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359451": [{"title": "GPA N1053B"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Never;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): NoNasalGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: PR3;\tage: 48;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 5;\tflares (number of relapses): 2;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 0;\tsmoking_pkyrs: 7;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): Rituximab;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359452": [{"title": "GPA N1055B"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Inactive;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): InactiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Limited;\tanca: PR3;\tage: 47;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 9;\tflares (number of relapses): 2;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 2;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359453": [{"title": "GPA N1057A"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Never;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): NoNasalGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: MPO;\tage: 75;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 6;\tflares (number of relapses): 3;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 3;\tsmoking_pkyrs: 45;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359454": [{"title": "GPA N1058"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Inactive;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): InactiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: PR3;\tage: 29;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 3;\tflares (number of relapses): 2;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 1;\tbvas: 1;\tvdi: 0;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): Methotrexate;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359455": [{"title": "GPA N1060"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Never;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): NoNasalGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: PR3;\tage: 58;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 5;\tflares (number of relapses): 1;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 0;\tsmoking_pkyrs: 25;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 10;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Rituximab;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359456": [{"title": "GPA N1061"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Active;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): ActiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: PR3;\tage: 55;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 0.5;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 2;\tbvas: 9;\tvdi: 1;\tsmoking_pkyrs: 30;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 30;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 1"}]}, {"GSM3359457": [{"title": "Control N1064"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Healthy;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 57;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359458": [{"title": "Control N1066"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Healthy;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 71;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 30;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359459": [{"title": "Control N1068"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Sarcoidosis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 51;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: Y;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359460": [{"title": "Control N1069"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Sarcoidosis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 51;\trace: Black;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): Methotrexate/Infliximab;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359461": [{"title": "Control N1070"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Sarcoidosis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 43;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 10;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 5;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 1"}]}, {"GSM3359462": [{"title": "EGPA N1073"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: EGPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): NA;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): EGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: MPO;\tage: 56;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 2;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: .;\tvdi: 0;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 5;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Methotrexate;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359463": [{"title": "GPA N1074"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Inactive;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): InactiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Limited;\tanca: PR3;\tage: 71;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 11;\tflares (number of relapses): 2;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 3;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): Methotrexate;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359464": [{"title": "Control N1081"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Healthy;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 62;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359465": [{"title": "Control N1082"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Sarcoidosis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 45;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 1;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: Y;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359466": [{"title": "Control N1086"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): AllergicRhinitis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 41;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359467": [{"title": "Control N1087"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Sarcoidosis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 51;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 0.5;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 20;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Methotrexate;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359468": [{"title": "GPA N1088"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Inactive;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): InactiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: PR3;\tage: 23;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 5;\tflares (number of relapses): 1;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 2;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 5;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 1"}]}, {"GSM3359469": [{"title": "GPA N1091"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Inactive;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): InactiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: PR3;\tage: 64;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 10;\tflares (number of relapses): 7;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 5;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 7;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Mycophenolate mofetil;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359470": [{"title": "Control N1092"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Healthy;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 59;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359471": [{"title": "EGPA N1094"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: EGPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): NA;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): EGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 63;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 14;\tflares (number of relapses): 4;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 5;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): Azathioprine;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359472": [{"title": "EGPA N1095"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: EGPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): NA;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): EGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 52;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tflares (number of relapses): 2;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 4;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 10;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Azathioprine;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359473": [{"title": "EGPA N1096"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: EGPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): NA;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): EGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: MPO;\tage: 64;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): 6;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 1;\tvdi: 4;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 2;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Methotrexate;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359474": [{"title": "Control N1097"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Healthy;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 66;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): .;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 0;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 0"}]}, {"GSM3359475": [{"title": "Control N1098"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Sarcoidosis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 59;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 8;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): Methotrexate;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359476": [{"title": "Control N1099"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: Control;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Control;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): Sarcoidosis;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 53;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 3;\tflares (number of relapses): .;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): .;\tbvas: .;\tvdi: .;\tsmoking_pkyrs: 18;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 20;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 1"}]}, {"GSM3359477": [{"title": "GPA N1100"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: GPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): Active;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): ActiveGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: PR3;\tage: 43;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 0.1;\tflares (number of relapses): 0;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 6;\tbvas: 8;\tvdi: 0;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 60;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 1"}]}, {"GSM3359478": [{"title": "EGPA N1101"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: EGPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): NA;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): EGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: MPO;\tage: 68;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 6;\tflares (number of relapses): 4;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 2;\tbvas: 3;\tvdi: 1;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 15;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 1"}]}, {"GSM3359479": [{"title": "EGPA N1102"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: EGPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): NA;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): EGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: MPO;\tage: 68;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 3;\tflares (number of relapses): 1;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 1;\tbvas: 1;\tvdi: 3;\tsmoking_pkyrs: 30;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 0;\tsteroids_cat: 0;\timmune_meds (recorded at time of sample collection): Methotrexate;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359480": [{"title": "EGPA N1103"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: EGPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): NA;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): EGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 42;\trace: White;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 10;\tflares (number of relapses): 3;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 5;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 5;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Methotrexate;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359481": [{"title": "EGPA N1104"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: EGPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): NA;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): EGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): Severe;\tanca: MPO;\tage: 50;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 7;\tflares (number of relapses): 4;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 4;\tvdi: 0;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 50;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 1"}]}, {"GSM3359482": [{"title": "EGPA N1105"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: EGPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): NA;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): EGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 28;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 10;\tflares (number of relapses): 9;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 5;\tbvas: 5;\tvdi: 5;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 20;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Rituximab;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359483": [{"title": "EGPA N1106"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: EGPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): NA;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): EGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 73;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 2;\tflares (number of relapses): 1;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 5;\tsmoking_pkyrs: 40;\tsmoking_status: Former;\tsteroids_daily_pred_mg: 10;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Azathioprine;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359484": [{"title": "EGPA N1107"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: EGPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): NA;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): EGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 70;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 4;\tflares (number of relapses): 1;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 1;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 2;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Mycophenolate mofetil;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359485": [{"title": "EGPA N1108"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: EGPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): NA;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): EGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: Neg;\tage: 56;\trace: White;\tgender: F;\tethnicity: non-Hisp;\tdisease_duration (yrs): 25;\tflares (number of relapses): 4;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 0;\tbvas: 0;\tvdi: 4;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 5;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): Azathioprine;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 1;\tany_immune: 1"}]}, {"GSM3359486": [{"title": "EGPA N1110"}, {"type": "RNA"}, {"source_name_ch1": "Nasal brushings"}, {"characteristics_ch1": "tissue: Nasal brushings;\tdisease: EGPA;\tdisease_activity (active means ongoing active nasal inflammation, inactive means a history of prior nasal inflammation, never means no history of nasal involvement): NA;\tbatch: 3;\tclassification (c1 = healthy control; c2= sarcoidosis; c3 = allergic rhinitis; c4 = egpa): EGPA;\tseverity (severe = organ threatening manifestations (e.g. glomerulonephritis or alveolar hemorrhage). limited = non severe disease.): N/A;\tanca: MPO;\tage: 38;\trace: Asian;\tgender: M;\tethnicity: non-Hisp;\tdisease_duration (yrs): 5;\tflares (number of relapses): 3;\tpga (physician global assessment - scale 0 to 10 with 10 meaning very active disease): 1;\tbvas: 1;\tvdi: 4;\tsmoking_pkyrs: 0;\tsmoking_status: Never;\tsteroids_daily_pred_mg: 8;\tsteroids_cat: 1;\timmune_meds (recorded at time of sample collection): None;\tgc_or_immune (prednisone or any immune med at time of sample collection): 1;\tnasal_steroids: N;\timmune_or_nasal: 0;\tany_immune: 1"}]}]}